» Articles » PMID: 36765598

The Relationship Between Cancer and Dementia: An Updated Review

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2023 Feb 11
PMID 36765598
Authors
Affiliations
Soon will be listed here.
Abstract

The risk of cancer and dementia increases with age, raising complex questions about whether it is appropriate to continue cancer treatment in older patients. There is emerging research suggesting the association between cancer and dementia. However, the mechanistic underpinnings are still under investigation. Progress has already been made toward understanding the cognitive effects associated with cancer therapy. Such associations raise awareness about the need to establish better prevention methods and early screening in clinical practice. Additionally, recent studies have suggested possible therapeutic strategies for better preserving cognitive function and reducing the risk for dementia before patients start cancer treatment. We review the current literature and summarize the incidence and mechanisms of cognitive impairment in patients with lung cancer, breast cancer, head and neck cancer, gastric cancer, prostate cancer, colorectal cancer, and brain tumor/brain metastasis following different kinds of therapies. Possible risk factors are suggested to identify the early onset of cognitive changes in cancer patients and provide more insight into the pathophysiological process of dementia.

Citing Articles

Bidirectional association between breast cancer and dementia: a systematic review and meta-analysis of observational studies.

Bao F, Yu L, Zhang X, Mu Q PeerJ. 2025; 13:e18888.

PMID: 39902325 PMC: 11789662. DOI: 10.7717/peerj.18888.


Effects of physical and psychological multimorbidity on the risk of dementia: multinational prospective cohorts and a meta-analysis.

Du M, Liu M, Liu J BMC Med. 2024; 22(1):423.

PMID: 39334426 PMC: 11437643. DOI: 10.1186/s12916-024-03642-2.


Alzheimer Disease and Related Dementia Following Hormone-Modulating Therapy in Patients With Breast Cancer.

Cai C, Strickland K, Knudsen S, Tucker S, Chidrala C, Modugno F JAMA Netw Open. 2024; 7(7):e2422493.

PMID: 39012631 PMC: 11252894. DOI: 10.1001/jamanetworkopen.2024.22493.


Increased Risk of Alzheimer's Disease in Patients with Head and Neck Cancer.

Lee I, Yu H, Ha S, Yang H, Kim D Cancers (Basel). 2023; 15(23).

PMID: 38067220 PMC: 10705604. DOI: 10.3390/cancers15235516.


Neurocognition and mean radiotherapy dose to vulnerable brain structures: new organs at risk?.

Soderstrom H, Walfridsson A, Martinsson U, Isacsson U, Brocki K, Kleberg J Radiat Oncol. 2023; 18(1):132.

PMID: 37568180 PMC: 10416465. DOI: 10.1186/s13014-023-02324-2.

References
1.
Lloret A, Fuchsberger T, Giraldo E, Vina J . Molecular mechanisms linking amyloid β toxicity and Tau hyperphosphorylation in Alzheimer׳s disease. Free Radic Biol Med. 2015; 83:186-91. DOI: 10.1016/j.freeradbiomed.2015.02.028. View

2.
Ongnok B, Chattipakorn N, Chattipakorn S . Doxorubicin and cisplatin induced cognitive impairment: The possible mechanisms and interventions. Exp Neurol. 2019; 324:113118. DOI: 10.1016/j.expneurol.2019.113118. View

3.
Ahtiluoto S, Polvikoski T, Peltonen M, Solomon A, Tuomilehto J, Winblad B . Diabetes, Alzheimer disease, and vascular dementia: a population-based neuropathologic study. Neurology. 2010; 75(13):1195-202. DOI: 10.1212/WNL.0b013e3181f4d7f8. View

4.
Lehrer E, Peterson J, Zaorsky N, Brown P, Sahgal A, Chiang V . Single versus Multifraction Stereotactic Radiosurgery for Large Brain Metastases: An International Meta-analysis of 24 Trials. Int J Radiat Oncol Biol Phys. 2018; 103(3):618-630. DOI: 10.1016/j.ijrobp.2018.10.038. View

5.
Vardy J, Dhillon H, Pond G, Rourke S, Bekele T, Renton C . Cognitive Function in Patients With Colorectal Cancer Who Do and Do Not Receive Chemotherapy: A Prospective, Longitudinal, Controlled Study. J Clin Oncol. 2015; 33(34):4085-92. PMC: 5683012. DOI: 10.1200/JCO.2015.63.0905. View